Adagio medical announces pricing of up to $50 million private placement of securities

Laguna hills, calif.--(business wire)--adagio medical holdings, inc. (nasdaq: adgm) (“adagio” or the “company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that it has entered into a securities purchase agreement with certain accredited investors to purchase shares of its common stock (or pre-funded warrants in lieu thereof), and accompanying common warrants (“warrants”) that is expected to result in approximately $19 million.
ADGM Ratings Summary
ADGM Quant Ranking